218 related articles for article (PubMed ID: 7962311)
1. Pathogenesis of the decreased androgen levels in obese men.
Giagulli VA; Kaufman JM; Vermeulen A
J Clin Endocrinol Metab; 1994 Oct; 79(4):997-1000. PubMed ID: 7962311
[TBL] [Abstract][Full Text] [Related]
2. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men.
Vermeulen A; Kaufman JM; Deslypere JP; Thomas G
J Clin Endocrinol Metab; 1993 May; 76(5):1140-6. PubMed ID: 8496304
[TBL] [Abstract][Full Text] [Related]
3. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
Vermeulen A; Kaufman JM; Giagulli VA
J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
[TBL] [Abstract][Full Text] [Related]
4. Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat.
Lima N; Cavaliere H; Knobel M; Halpern A; Medeiros-Neto G
Int J Obes Relat Metab Disord; 2000 Nov; 24(11):1433-7. PubMed ID: 11126339
[TBL] [Abstract][Full Text] [Related]
5. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA; Wallace AM; Wu FC
J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
[TBL] [Abstract][Full Text] [Related]
6. Androsterone sulfate: physiology and clinical significance in hirsute women.
Zwicker H; Rittmaster RS
J Clin Endocrinol Metab; 1993 Jan; 76(1):112-6. PubMed ID: 8380602
[TBL] [Abstract][Full Text] [Related]
7. Elevated production and metabolic clearance rates of androgens in morbidly obese women.
Samojlik E; Kirschner MA; Silber D; Schneider G; Ertel NH
J Clin Endocrinol Metab; 1984 Nov; 59(5):949-54. PubMed ID: 6480813
[TBL] [Abstract][Full Text] [Related]
8. Increased free testosterone but normal 5 alpha-reduced testosterone metabolites in obese premenopausal women.
Giagulli VA; De Pergola G; Giorgino F; Cignarelli M; Abbaticchio G; Vermeulen A; Giorgino R
Clin Endocrinol (Oxf); 1992 Jun; 36(6):553-8. PubMed ID: 1424180
[TBL] [Abstract][Full Text] [Related]
9. Effect of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) on serum androgen markers in normal-weight, obese, and extremely obese women.
Segall-Gutierrez P; Du J; Niu C; Ge M; Tilley I; Mizraji K; Stanczyk FZ
Contraception; 2012 Dec; 86(6):739-45. PubMed ID: 22959905
[TBL] [Abstract][Full Text] [Related]
10. The effects of metformin and diet on plasma testosterone and leptin levels in obese men.
Ozata M; Oktenli C; Bingol N; Ozdemir IC
Obes Res; 2001 Nov; 9(11):662-7. PubMed ID: 11707532
[TBL] [Abstract][Full Text] [Related]
11. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases.
Kiddy DS; Sharp PS; White DM; Scanlon MF; Mason HD; Bray CS; Polson DW; Reed MJ; Franks S
Clin Endocrinol (Oxf); 1990 Feb; 32(2):213-20. PubMed ID: 2112067
[TBL] [Abstract][Full Text] [Related]
12. Effect of MK-906, a specific 5 alpha-reductase inhibitor, on serum androgens and androgen conjugates in normal men.
Rittmaster RS; Stoner E; Thompson DL; Nance D; Lasseter KC
J Androl; 1989; 10(4):259-62. PubMed ID: 2550402
[TBL] [Abstract][Full Text] [Related]
13. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study.
Gray A; Feldman HA; McKinlay JB; Longcope C
J Clin Endocrinol Metab; 1991 Nov; 73(5):1016-25. PubMed ID: 1719016
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
Stanczyk FZ; Saxena T; Lobo RA
J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
[TBL] [Abstract][Full Text] [Related]
15. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels.
Isidori AM; Caprio M; Strollo F; Moretti C; Frajese G; Isidori A; Fabbri A
J Clin Endocrinol Metab; 1999 Oct; 84(10):3673-80. PubMed ID: 10523013
[TBL] [Abstract][Full Text] [Related]
16. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate.
Tenover JS; Matsumoto AM; Plymate SR; Bremner WJ
J Clin Endocrinol Metab; 1987 Dec; 65(6):1118-26. PubMed ID: 3119649
[TBL] [Abstract][Full Text] [Related]
17. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
18. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men.
Castro-Fernández C; Olivares A; Söderlund D; López-Alvarenga JC; Zambrano E; Veldhuis JD; Ulloa-Aguirre A; Méndez JP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4603-10. PubMed ID: 11134115
[TBL] [Abstract][Full Text] [Related]
19. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
[TBL] [Abstract][Full Text] [Related]
20. Serum androgen levels in hyperthyroid women.
Ueshiba H; Takeda S; Matoba H; Tanaka Y; Yuasa R; Tsuboi K; Miyachi Y
Exp Clin Endocrinol Diabetes; 1997; 105(6):359-62. PubMed ID: 9439933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
